RxSight, Inc. (RXST)
After hours:
| Previous Close | 52.13 |
| Open | 52.46 |
| Bid | 56.61 x 100 |
| Ask | 56.98 x 100 |
| Day's Range | 52.00 - 57.76 |
| 52 Week Range | 18.09 - 58.21 |
| Volume | |
| Avg. Volume | 398,080 |
| Market Cap | 2.108B |
| Beta (5Y Monthly) | 1.22 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.41 |
| Earnings Date | May 06, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 62.71 |
GlobeNewswireRxSight, Inc. to Present at the Bank of America Healthcare Conference
ALISO VIEJO, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Bank of America Healthcare Conference. RxSight’s management is scheduled to present on Wednesday, May 15, 2024, at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at:
Simply Wall St.Should You Investigate RxSight, Inc. (NASDAQ:RXST) At US$52.84?
While RxSight, Inc. ( NASDAQ:RXST ) might not have the largest market cap around , it saw a decent share price growth...
- GlobeNewswire
RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
ALISO VIEJO, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the first quarter of 2024 after the market close on Monday, May 6, 2024. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. To participat
